A Study to Improve Physician-Youth Communication and Medical Decision Making (CHATT)

June 3, 2025 updated by: Melissa Cousino, University of Michigan

We Chatt (Communication, Hopes, Action, Tips and Team) A Study to Improve Physician-Youth Communication and Medical Decision Making

The goal of this study is improving patient-centered communication for young people with advanced heart disease.

Study Overview

Study Type

Interventional

Enrollment (Actual)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • University of Michigan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Physician Inclusion Criteria:

  • Physician participants will be recruited from the Division of Pediatric Cardiology at the University of Michigan. All physicians with dedicated clinical effort will be eligible.
  • Eligible physicians must anticipate remaining on staff >1 year

Patient/Caregiver Inclusion Criteria:

  • Patients 12-24 years old with heart failure symptoms meeting criteria for New York Heart Association (NYHA) Class II - IV heart failure
  • One parent/caregiver of patient participants meeting inclusion criteria will also be eligible

Physician Exclusion Criteria:

- Not a physician at University of Michigan in the Division of Pediatric Cardiology

Patient/Caregiver Exclusion Criteria:

  • Patients with significant cognitive/developmental delay with potential to impact study participation will be excluded from the study due to the focus on physician-youth communication.
  • Parents and parent/caregivers that are non-English speaking will be excluded from this pilot study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Usual care
Usual/standard care will be provided. Physicians randomized to the control arm will not receive training in the WE CHATT communication intervention.
Experimental: We Chatt communication tool
This arm involves the collaborative completion of a 2-page communication preferences document between a primary physician and an adolescent/young adult patient. Physicians will participate in a 1-hour training led by study principal investigator featuring didactic, multimedia, and experiential-based learning to support the facilitation of the WE CHATT intervention with patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physician Overall Satisfaction With the We Chatt Intervention Based on the Post Clinician Survey
Time Frame: 2 weeks (after intervention)
Satisfaction was based on the answers for 12 questions in which clinicians selected from a Likert scale from strongly disagree (1) -Strongly agree (5). The scores ranged from 12-60; higher scores indicated greater satisfaction.
2 weeks (after intervention)
Patient/Caregiver Overall Satisfaction With the We Chatt Intervention Based on the Patient/Caregiver Survey
Time Frame: 2 weeks (after intervention)
Parent/Caregiver completed 12 questions in which participants selected from a Likert scale from Strongly disagree (1) to Strongly agree (5). The scores ranged from 12-60; higher scores indicated greater satisfaction.
2 weeks (after intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physician Satisfaction With the We Chatt Intervention From Physicians Based on the Post Clinician Survey
Time Frame: 2 weeks (after intervention)
Physicians answered 1 question on a scale from 0 to 10 (with 0 being worst and 10 being best)
2 weeks (after intervention)
Patient/Caregiver Satisfaction With the We Chatt Intervention Based on the Patient/Caregiver Survey
Time Frame: 2 weeks (after intervention)
Patient/Caregiver answered 1 question on a scale from 0 to 10 (with 0 being worst and 10 being best)
2 weeks (after intervention)
Time (Measured in Minutes) to Complete We Chatt the Intervention by Clinicians
Time Frame: 30 minutes (approximately)
Number of minutes to complete the intervention was collected on clinician survey.
30 minutes (approximately)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Melissa Cousino, PhD, University of Michigan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 14, 2023

Primary Completion (Actual)

June 7, 2024

Study Completion (Actual)

June 7, 2024

Study Registration Dates

First Submitted

April 17, 2023

First Submitted That Met QC Criteria

April 17, 2023

First Posted (Actual)

April 28, 2023

Study Record Updates

Last Update Posted (Actual)

June 18, 2025

Last Update Submitted That Met QC Criteria

June 3, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HUM00231699
  • 5K23HL145096-04 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure NYHA Class II

Clinical Trials on We Chatt communication tool

Subscribe